Jiangsu Yew Pharmaceutical

Jiangsu Yew Pharmaceutical is a specialized pharmaceutical company based in China that focuses on the development, production, and sale of taxane-based anti-tumor drugs. As a subsidiary of the Hodo Group (Hongdou Group), the company leverages a large-scale Taxus chinensis plantation to ensure a sustainable supply of raw materials for Paclitaxel extraction. Its core business includes the manufacturing of high-purity Active Pharmaceutical Ingredients (APIs) and finished dosage forms, such as Paclitaxel and Docetaxel injections. The company is recognized for its integrated industrial chain, spanning from seedling cultivation to the production of advanced oncology therapeutics. Jiangsu Yew Pharmaceutical serves both domestic and international markets, maintaining GMP-compliant facilities to support its oncology portfolio.